Lamotrigine
Product Images NDC 50436-0149

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 50436-0149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 01)

FDA Label Image

Figure 1 (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 02)

FDA Label Image

Figure 2 (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 03)

FDA Label Image

Tablet (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 04)

Tablet (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 04)
Lamotrigine is a medication that comes in tablet form with strengths of 25mg, 100mg, and 150mg. The tablets are light pink in color and are imprinted with different codes for identification. However, the exact imprint codes are not available due to errors.*
FDA Label Image

Label Image (Lbl504360149)

Label Image (Lbl504360149)
This is a medication packaging of Lamotrigine, with a strength of 100mg and 30 capsules in a container. The manufacturer of this medication is Cipla Ltd, and it is dispensed in a container designed in Verna, GOA India. The Pharmacist should store and dispense the medication at controlled room temperature, as labeled in the packaging. There is a warning for keeping it out of reach of children. The packaging also includes a dosage information package insert for the pharmacist to follow. There are multiple lot numbers and expiration dates mentioned for the medication in the packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.